NCT05251493View on ClinicalTrials.gov

Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

PHASE3RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
Iron Deficiency Anaemia in Childbirth
Interventions
DRUG

Iron Isomaltoside 1000, ferric derisomaltose

iron isomaltoside 20 mg/mL

DRUG

Iron sucrose

iron sucrose 100 mg/mL

Trial Locations (1)

S4P 0W5

RECRUITING

Regina General Hospital, Regina

All Listed Sponsors
collaborator

Saskatchewan Centre for Patient-Oriented Research

OTHER

lead

Saskatchewan Health Authority - Regina Area

OTHER